Markets
BSE See NSE See 27,865.96
38.43 (0.14%)

Aurobindo Pharma Gets USFDA Approval For Generic Diovan HCT

By Shrikant Akolkar | 3/22/2013 3:42 PM Friday

Aurobindo Pharma has reported receiving final approval for the Valsartan and Hydrochlorothiazide tablets (brand name Diovan HCT held by Novartis). The drug is indicated in the treatment of hypertension to lower blood pressure. The market size of this drug is USD 1.7 billion (Rs 9350 crore) as per the company’s BSE filings. Aurobindo has said that the product is ready for launch and that this will happen soon.

Drug major Mylan has already launched an authorised generic version of this drug in USA. We believe that Aurobindo is the first to launch the generic of this drug considering that Mylan’s was an authorised generic.

We spoke to the company spokesperson, who declined to comment on the pricing and market share of the drug. However, he did say that the company expects to see about 3-4 generic players in the market. Considering this, about 20% market share looks achievable for Aurobindo. Since it is the first to launch, there would not be a massive erosion of price initially. However, as the drug has already fallen out of patent cover, new players would try to enter the market as faster as possible. Once other companies start launching their versions of the drug, the price will go down.

Considering 80% price erosion and 10% market share for Aurobindo, it can be estimated that the company may achieve revenues of about Rs 700 crore from the drug. Of course, these numbers are based on the assumption that the company makes the best of this opportunity.

With this approval, Aurobindo Pharma has a total of 181 ANDA approvals from USFDA, of which 156 are final and 25 are tentative approvals.

Find More Articles on: Markets, DSIJ Mindshare, Product, Large Cap

collapse Related Readings collapse

DSIJ
Mindshare

Indices bounce back

Indices bounce back

The Indian markets witnessed a good recovery at closing buzz, on September's last trading session. Auto index outperformed the day followed by Mid-caps and Small-caps. The Sensex ended 38 points higher at 27865 and Nifty was up 20 points at 8611. Both the indices closed with a positive bias around 0.14-0.23 per cent respectively.

Overnight Digest – Stocks to look out for on October 3

Overnight Digest – Stocks to look out for on October 3

The stocks which could witness significant movement on October 3 are Edelweiss Financial Services, Arman Financial Services, Gati/ Snowman Logistics/ Gateway Distriparks, NHPC, ONGC/Petronet LNG/ Oil India.

Cipla tanks 6 per cent in trade on US FDA observations for Goa units

Cipla tanks 6 per cent in trade on US FDA observations for Goa units

Mumbai- headquartered pharmaceutical company, Cipla said in an exchange filing that US FDA recently concluded audit of three facilities at Goa and subsequently issued four observations pertaining to the audit carried out.

Breweries rule Dalal Street after Patna High Court stay order on govt's policy

Breweries rule Dalal Street after Patna High Court stay order on govt's policy

The Patna High Court smashed down the Bihar Government’s imposition of total prohibition in the state. The Bihar Prohibition and Excise Bill-2016, which came into effect on April 5, 2016 was deemed illegal by a division bench of the court.

Alkem Laboratories cracks 8 per cent on US FDA observations

Alkem Laboratories cracks 8 per cent on US FDA observations

Mumbai based pharma major, Alkem Laboratories in an exchange filing informed the exchanges that the company has received the inspection report which contains thirteen 483 observations.

Markets @ 2 pm: Movers and Shockers

Markets @ 2 pm: Movers and Shockers

Following are the top gainers and losers as of September 30. Dishman Pharma is the largest gainer; whereas Alkem Lab  is the largest loser.

Mid-market commentary September 30, 2016

Mid-market commentary September 30, 2016

The Indian markets are flattish at mid-market session. Market witnessed some stock specific action. The Nifty has seen some sideways move, up by 2 points at 8600 and the Sensex is up by 5 points at 27830.

Three new players in F&O segment from October series

Three new players in F&O segment from October series

Shares of IDFC Bank, DCB Bank and Torrent Power will remain in focus, as these stocks will enter the derivative segment from Friday.  The share prices of these companies increased by 3.47 per cent, 4.76 per cent and 4.04 per cent on bourses in early trades.

Markets @ 11 am: Movers and Shockers

Markets @ 11 am: Movers and Shockers

Following are the top gainers and losers as of September 30. TVS Srichakra is the largest gainer; whereas Alkem Lab is the largest loser.

Sintex Industries surges after demerger scheme

Sintex Industries surges after demerger scheme

Sintex Industries’ board has approved demerger of custom moulding business and prefab business from its two arms Sintex BAPL and Sintex Infra Projects. Both the companies are wholly-owned subsidiaries of Sintex Plastic Technologies, Sintex Industries, respectively.

Subscribe to
Newsletter

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

Market
CHIT CHAT

What is your view on markets today?

200  Characters Remaining.
Please LOGIN  to post your comments or Click here to go back.
sln sudharsan Sep 30 06:57PM
Nifty taken support at around 8580 levels. Upward move possible . Target 8675
sln sudharsan Sep 30 06:54PM
Buy Maruti Suzuki for a jump of Rs.150 from here.
Rohit sharma Sep 30 05:37PM
its updated please check
Shivesh Singh Sep 30 03:54PM
IPO doesn't show here, it will show in a weeks time
Rahul Rajodiya Sep 30 03:34PM
i also face same problem #himanshu